Breast – Invasive breast cancer of no special type (NST) with weak TFE3 staining of a subset of tumor cells
Breast – TFE3 negative invasive breast cancer of no special type (NST)
Breast – TFE3 negative invasive lobular breast cancer
Colon – TFE3 negative colorectal adenocarcinoma (2)
Colon – TFE3 negative colorectal adenocarcinoma
Esophagus – Squamous cell carcinoma with weak TFE3 positivity of large fraction of tumor cells
Esophagus – TFE3 negative adenocarcinoma
Esophagus – TFE3 negative squamous cell carcinoma
Kidney – Oncocytoma with faint TFE3 staining of a fraction of tumor cells
Kidney – Papillary renal cell carcinoma with faint TFE3 staining of a fraction of umor cells
Kidney – TFE3 negative papillary renal cell carcinoma (2)
Kidney – TFE3 negative papillary renal cell carcinoma (2)
Kidney – TFE3 negative papillary renal cell carcinoma
Kidney – Xp11.2 fusion carcinoma with strong TFE3 staining of all tumor cells (2)
Kidney – Xp11.2 fusion carcinoma with strong TFE3 staining of all tumor cells
Oral cavity – TFE3 negative squamous cell carcinoma
Ovary – TFE3 negative clear cell carcinoma (2)
Ovary – TFE3 negative clear cell carcinoma
Ovary – TFE3 negative endometroid carcinoma
Pharynx – Squamous cell carcinoma with faint TFE3 positivity of a subset of tumor cells
Prostate – TFE3 negative adenocarcinoma (Gleason 3+3=6)
Prostate – TFE3 negative adenocarcinoma (Gleason 4+4=8)
Thyroid – Follicular cancer with weak TFE3 immunostaining of tumor cells
Urinary bladder – TFE3 negative non-invasive papillary urothelial carcinoma (pTa)